LTRN
Lantern Pharma Inc. - Common Stock (LTRN)
$53
About Lantern Pharma Inc. - Common Stock (LTRN)
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Details
Daily high
$0.58
Daily low
$0.52
Price at open
--
52 Week High
$4.34
52 Week Low
$0.52
Market cap
8.8M
Dividend yield
-
Volume
27
Avg. volume
284,210
P/E ratio
-.36
Lantern Pharma Inc. - Common Stock News
Details
Daily high
$0.58
Daily low
$0.52
Price at open
--
52 Week High
$4.34
52 Week Low
$0.52
Market cap
8.8M
Dividend yield
-
Volume
27
Avg. volume
284,210
P/E ratio
-.36